 |
|
Prognostic assessment of sarcomatous histologic subtypes of ovarian carcinosarcoma
Hyun Jin Kim, Hyun-Mi Lee, Mi Kyung Kim, Yoo-Kyung Lee, In-Ho Lee, Ki-Heon Lee, Hyesun Kim
Obstet Gynecol Sci. 2017;60(4):350-356. Published online 2017 Jul 14 DOI: https://doi.org/10.5468/ogs.2017.60.4.350
|
|
Citations to this article as recorded by
 Ovarian Carcinosarcoma: Rare Histology Which Never Fails to be Aggressive
Dimpy Begum, Aparajita, Upasana Baruah, Debabrata Barmon
The Journal of Obstetrics and Gynecology of India.2023;[Epub] CrossRef Prognostic significance of heterologous component in carcinosarcoma of the gynecologic organs: a systematic review and meta-analysis
Younghoon Kim, Gyeong Hoon Kang, Haeryoung Kim
Journal of Gynecologic Oncology.2023;[Epub] CrossRef Frontiers of Ovarian Carcinosarcoma
Ayden Ismail, Sunyoung Choi, Stergios Boussios
Current Treatment Options in Oncology.2023;[Epub] CrossRef Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network
Clémence Romeo, Olivia Le Saux, Margaux Jacobs, Florence Joly, Gwenael Ferron, Laure Favier, Jean-David Fumet, Nicolas Isambert, Pierre-Emmanuel Colombo, Renaud Sabatier, Ludovic Bastide, Amandine Charreton, Mojgan Devouassoux-Shisheboran, Witold Gertych,
Cancers.2022; 14(2): 354. CrossRef The clinical characteristics and treatment of ovarian malignant mesoderm mixed tumor: a systematic review
Xin Wang, Shiyuan Wang, Shujuan Yao, Wei Shi, Ke Ma
Journal of Ovarian Research.2022;[Epub] CrossRef Ovarian carcinosarcoma (a literature review)
A. M. Beishembaev, K. I. Zhordania, E. D. Choi, A. A. Turkmenov, A. K. Moldobekova
Obstetrics, Gynecology and Reproduction.2022; 16(5): 575. CrossRef T-Cell Receptor Therapy in the Treatment of Ovarian Cancer: A Mini Review
Jessica W. Y. Wu, Sudiksha Dand, Lachlan Doig, Anthony T. Papenfuss, Clare L. Scott, Gwo Ho, Joshua D. Ooi
Frontiers in Immunology.2021;[Epub] CrossRef
|